Welcome to LookChem.com Sign In|Join Free
  • or
3,5-diisopropyl-2-methylbenzene-1,4-diol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

153475-03-7

Post Buying Request

153475-03-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

153475-03-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 153475-03-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,4,7 and 5 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 153475-03:
(8*1)+(7*5)+(6*3)+(5*4)+(4*7)+(3*5)+(2*0)+(1*3)=127
127 % 10 = 7
So 153475-03-7 is a valid CAS Registry Number.

153475-03-7Relevant academic research and scientific papers

COMPOUND FOR THE PROPHYLAXIS OR TREATMENT OF ORGAN DAMAGE

-

Page/Page column 10; 11; 14; 15, (2016/12/22)

The present invention relates to compounds for prophylaxis or treatment of organ damage by restoring endothelial function and/or inhibiting reactive oxygen species production and especially to compounds for prophylaxis or treatment of diabetic kidney dama

6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-COMPOUNDS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE AIRWAY DISEASES

-

, (2016/05/24)

The present invention relates to compounds for the treatment of chronic obstructive airway diseases such as chronic obstructive pulmonary disease (COPD) or asthma or bronchiectasis. The present invention further relates to drug delivery devices suitable t

COMPOUNDS FOR PROTECTION OF CELLS

-

Page/Page column 34-35; 40-41, (2014/07/08)

This invention is related to a compound with the structural formula (I). Wherein, R1, and R2 are independently selected from the group consisting of C1-C6 alkyl and is preferably methyl, ethyl, propyl or isopropyl; R3 is selected fro

Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

-

Page/Page column 18, (2010/11/26)

Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), or Kearns-Sayre Syndrome (KSS) are disclosed,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 153475-03-7